in Share Stories & News

Hallucinations in AI: How GSK is addressing a critical problem in drug development

161 Views

Hallucinations in AI: How GSK is addressing a critical problem in drug development

Hallucinations are a persistent problem in healthcare. Here’s how GSK is using test-time compute scaling to improve its gen AI systems…

Report

What do you think?

0 Points
Upvote Downvote

Browse and manage your votes from your Member Profile Page

Newbie

Written by Mr Viral

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Google’s Gemini AI just shattered the rules of visual processing — here’s what that means for you

Google’s Gemini AI just shattered the rules of visual processing — here’s what that means for you
MiniMax unveils its own open source LLM with industry-leading 4M token context

MiniMax unveils its own open source LLM with industry-leading 4M token context